MiR-4535 and MiR-1915-5p in Amniotic Fluid as Predictive Biomarkers for Chorioamnionitis
URUSHIYAMA Daichi; FUKAGAWA Satoshi; HIRAKAWA Toyofumi; YOSHIKAWA Ken-Ichi; IZUCHI Daisuke; MIYATA Kohei; KURAKAZU Masamitsu; YOTSUMOTO Fusanori; HIROMATSU Kenji; OTA Eiji; HIROSE Shinichi; YASUNAGA Shin'ichiro; MIYAMOTO Shingo
Future Science OA, 2021, Refereed

Clinical Features of Recurrence in Patients Without Residual Tumour in Endometrial Cancer
MIYAMOTO Shingo; YOTSUMOTO Fusanori; MIYAHARA Daisuke; HIRAKAWA Toyofumi; YOSHIKAWA Ken-Ichi; SHIGEKAWA Koichiro; MIYATA Kohei; ITO Tomohiro; KURAKAZU Masamitsu
Anticancer Research, Jul. 2019, 39:4581 - 4588, Refereed

The combination of maternal blood and amniotic fluid biomarkers improves the predictive accuracy of histologic chorioamnionitis
MIYAMOTO Shingo; KURAKAZU Masamitsu; YOTSUMOTO Fusanori; ARIMA Hisatomi; IZUCHI Daisuke; URUSHIYAMA Daichi; MIYATA Kohei; KIYOSHIMA Chihiro; FUKAGAWA Satoshi; YOSHIKAWA Ken-Ichi; HIRAKAWA Toyofumi; SHIGEKAWA Koichiro; SANUI Ayako; NABESHIMA Kazuki
Placenta, 2019, 80:4 - 7

Association of Serum HB-EGF Value and Response to Chemotherapy in Patients with Recurrent Ovarian Cancer
MIYAMOTO Shingo; IZUCHI Daisuke; FUKAGAWA Satoshi; YOTSUMOTO Fusanori; YOSHIKAWA Ken-Ichi; KIYOSHIMA Chihiro; NAN Son-U; MIYATA Kohei; ITO Tomohiro; KURAKAZU Masamitsu; ARAKI Ryota; SANUI Ayako; MIYAHARA Daisuke; MURATA Masaharu
Anticancer Res, 2018, 38(7):4347 - 4351, Refereed